TY - JOUR
T1 - Challenges in the pathology of non-muscle-invasive bladder cancer
T2 - A dialogue between the urologic surgeon and the pathologist
AU - Hansel, Donna E.
AU - Miller, Jeremy S.
AU - Cookson, Michael S.
AU - Chang, Sam S.
PY - 2013/6
Y1 - 2013/6
N2 - Approximately 70%-80% of urothelial carcinomas are detected at the stage of non-muscle-invasive bladder cancer (NMIBC). Initial management is often successful, but recurrence is common and leads to a long, burdensome, costly disease course. The quality and efficiency of care depends in part on accurate, clearly communicated descriptions of tumor characteristics. This review identifies current best practices, unmet needs, and key issues in the pathology of NMIBC for the practicing urologist. Reasonable and objective recommendations are provided with the goal of improving urologist-pathologist communication, the efficiency of healthcare utilization, and outcomes for patients with NMIBC.
AB - Approximately 70%-80% of urothelial carcinomas are detected at the stage of non-muscle-invasive bladder cancer (NMIBC). Initial management is often successful, but recurrence is common and leads to a long, burdensome, costly disease course. The quality and efficiency of care depends in part on accurate, clearly communicated descriptions of tumor characteristics. This review identifies current best practices, unmet needs, and key issues in the pathology of NMIBC for the practicing urologist. Reasonable and objective recommendations are provided with the goal of improving urologist-pathologist communication, the efficiency of healthcare utilization, and outcomes for patients with NMIBC.
UR - http://www.scopus.com/inward/record.url?scp=84878550425&partnerID=8YFLogxK
UR - http://www.scopus.com/inward/citedby.url?scp=84878550425&partnerID=8YFLogxK
U2 - 10.1016/j.urology.2013.01.027
DO - 10.1016/j.urology.2013.01.027
M3 - Article
C2 - 23522296
AN - SCOPUS:84878550425
SN - 0090-4295
VL - 81
SP - 1123
EP - 1130
JO - Urology
JF - Urology
IS - 6
ER -